# A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer

> **NCT01784107** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Gachon University Gil Medical Center** · enrollment: 45 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** Belotecan and Ifosfamide

## Key facts

- **NCT ID:** NCT01784107
- **Lead sponsor:** Gachon University Gil Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2018-07
- **Final completion:** —
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2016-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01784107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01784107, "A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01784107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*